Pharmafile Logo
Pharmafocus logo
Advanced Search

Daichii Sankyo

Showing 1 posts of 1 posts found.

Daiichi scores another NICE nod for Lixiana

August 12, 2015
Sales and Marketing Daichii Sankyo, Daiichi, Lixiana, atrial fibrillation, edoxaban

NICE has recommended in draft guidance the anti-blood clotting drug Daiichi Sankyo’s Lixiana for preventing stroke and blood clots in …

News
The Gateway to Local Adoption Series

Latest content

MHRA awards Innovation Passports to liver cancer and dementia medicines

August 7, 2026

Scottish NHS hospital adopts light-activated therapy to reduce surgical infections

August 6, 2026

Manchester launches nurse-led clinic to improve kidney transplant outcomes

August 5, 2026

Androlabs and Majorelle expand testosterone therapy into France

August 4, 2026

Promatix secures Innovate UK funding to advance bispecific ADC programme

August 3, 2026